H1B Report
Side-by-side comparison

Microsoft Corporation vs Tris Pharma, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Microsoft Corporation
WARank #5FEIN 91-1144442
Entity B
Tris Pharma, Inc.
NJRank #FEIN 22-3747409

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricMicrosoft CorporationTris Pharma, Inc.
Total filings72,912241
Certified %94.30%93.78%
Denied %0.15%1.66%
Withdrawn %0.69%3.73%
Cert-withdrawn %4.85%0.83%
Rank#5
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateWANJ

Outcomes — Microsoft Corporation

DOL case-status mix.

Outcome breakdown: Certified 94.3%, Cert-withdrawn 4.9%, Withdrawn 0.7%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%

Outcomes — Tris Pharma, Inc.

DOL case-status mix.

Outcome breakdown: Certified 93.8%, Cert-withdrawn 0.8%, Withdrawn 3.7%, Denied 1.7%
Outcome breakdown
OutcomeShare
Certified93.8%
Cert-withdrawn0.8%
Withdrawn3.7%
Denied1.7%
Certified93.8%
Cert-withdrawn0.8%
Withdrawn3.7%
Denied1.7%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Microsoft Corporation
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104,407
FY20114,184
FY20124,005
FY20133,832
FY20143,674
FY20154,476
FY20164,919
FY20174,884
FY20185,457
FY20196,000
FY202051
FY2021110
FY2022150
FY20232,791
FY20249,492
FY20259,362
FY20265,118
Tris Pharma, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20108
FY201115
FY201217
FY201316
FY201420
FY201518
FY201619
FY201717
FY201818
FY201915
FY20207
FY20215
FY20223
FY20238
FY202422
FY202518
FY202615

Top 5 occupations — Microsoft Corporation

Top 5 occupations — Tris Pharma, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Or browse the full sponsor index.